Holders — by stockHoldings — by fund
GENERAL ATLANTIC, L.P.
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001017645
$2.91B
disclosed book value
12
positions
20.9%
largest position share
Positions, as of 2026-06-30
top 12 of 12 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | LFTOLIFTOFF MOBILE | 25.3M | $608.1M | 20.9% |
| 2 | DLOCAL | 46.7M | $606.3M | 20.9% |
| 3 | CHYMCHIME | 21.3M | $435.4M | 15% |
| 4 | ALKTALKAMI | 19.4M | $351.1M | 12.1% |
| 5 | XP, INC | 20.6M | $334.4M | 11.5% |
| 6 | PHARVARIS | 6.6M | $226.5M | 7.8% |
| 7 | SPTXSEAPORT THERAPEUTICS | 6.1M | $132.5M | 4.6% |
| 8 | NRIXNURIX THERAPEUTICS | 3.0M | $73.6M | 2.5% |
| 9 | RVMDREVOLUTION MEDICINES | 357,791 | $67.0M | 2.3% |
| 10 | PBLSPARABILIS MEDICINES | 1.5M | $42.1M | 1.4% |
| 11 | RISKIFIED | 5.3M | $26.8M | 0.9% |
| 12 | GROVGROVE COLLABORATIVE | 2.5M | $3.1M | 0.1% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.